Modulation of endothelial prostaglandin synthesis by corticotropin releasing factor and antagonists

Author： Fleisher-Berkovich S.   Rimon G.   Danon A.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.353, Iss.2, 1998-07, pp. : 297-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small molecule corticotropin-releasing factor antagonists

By Lanier Marion   Williams John P  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1619-1630

Informa Healthcare

Access to resources Recommend Favorite

Modulation of the inflammatory response by corticotropin-releasing factor

By Correa S.G.   Riera C.M.   Spiess J.   Bianco I.D.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 85-90

Elsevier

Access to resources Recommend Favorite

Corticotropin-releasing factor 1 receptor antagonists: a patent review

By Williams John P  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1057-1068

Informa Healthcare

Access to resources Recommend Favorite

Corticotropin-Releasing Factor Antagonists: Therapeutic Potential in the Treatment of Affective Disorders

By Owens M.J.   Nemeroff C.B.  

CNS Drugs, Vol. 12, Iss. 2, 1999-08 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

Corticotropin-Releasing Factor Receptor Antagonists in Affective Disorders and Drug Dependence - An Update

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-04 ,pp. : 147-165

Bentham Science Publishers

Access to resources Recommend Favorite